LAM Treatment Alliance Fast Tracking Treatment Research

The LAM/TSC Seminar Series

Upcoming Seminars:
Past Seminars:

Next Seminar:

December 11, 2008 5-7PM EST

Topic: Developing Chemical Probes for the Genome and New Therapeutic Targets for LAM, TSC and Other Neglected Diseases: Studies From the NIH Chemical Genomics Center
Speaker: Christopher Austin, MD (NIH - NHGRI), Senior Advisor for Translational Research, NIH - National Human Genome Research Institute
Discussant: Lewis Cantley, PhD (HMS/BIDMC), Chief, Division of Signal Transduction and Director of the Cancer Center at Beth Israel Deconness Medical Center

RSVP: RSVP is required to attend meetings. Please send an email to amy_farber@hms.harvard.edu to RSVP and indicate the names and total number of people attending from your department or lab.

Request a Meeting: To request a meeting with Christopher Austin in the afternoon on December 11th please email amy_farber@hms.harvard.edu by November 25th.

Live Webcast: Live streaming of our monthly LAM/TSC Seminar Series is available. To obtain a password, please contact ltaadmin@lamtreatmentalliance.org .

Location: Seminars are held in room #350 in the New Research Building (NRB) at Harvard Medical School in Boston, Massachusetts, USA 02115.

Parking: Free parking in the lot below the New Research Building has been graciously donated. Space is limited and will be made available to participants coming from outside of the Longwood Medical Area if requested by December 11, 2008 at 11am EST.

LAM/TSC Seminar Series Overview and Logistics:

The LAM/TSC Seminar Series, now in its third year, is a monthly multi-disciplinary meeting ground where approximately 35-85 researchers and clinicians gather to:

  • Pool knowledge among those working separately, thereby increasing the potential impact of present research on LAM/TSC;
  • Identify gaps in research that might impact future work on LAM/TSC;
  • Foster interdisciplinary collaboration at clinical and basic science levels within the research community in Boston, throughout the United States and internationally both through on-site and remote participation via webcasts of the sessions;
  • Recruit junior and senior leaders in fields relevant to LAM/TSC research to work on LAM and TSC;
  • Brainstorm and peer review novel therapeutic approaches to finding effective treatments for LAM and TSC

CME credit is available to physicians attending these meetings.

We are so grateful to our sponsors and partners: the Tuberous Sclerosis Alliance; Harvard Medical School Department of Continuing Medical Education; Harvard Medical School Department of Genetics; David Kwiatkowski; LTA volunteers and LAM patients in the Boston area.

Upcoming Seminars
Past Seminars

LAM Treatment Alliance

E-mail: info@lamtreatmentalliance.org

Mailing Address: 87 Garden Street; Cambridge, MA 02138; USA

Phone: +1 (617) 460-7339

Fax: +1 (617) 864-0614


Sponsors, Partners and Supporters